Top Markets
Coin of the day
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Pozycja w akcjach #30829
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Cena akcji
$0.88649477
Kapitalizacja rynkowa
$15.33M
Zmiana (1 dzień)
-3.61%
Zmiana (1 rok)
-54.45%
Kraj
KR
Handel Xcell Therapeutics, Inc. (373110)

Kategoria

Historia stopy dywidendy dla Xcell Therapeutics, Inc. (373110)
Stopa dywidendy (TTM) dla Xcell Therapeutics, Inc. (symbol akcji: 373110) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Xcell Therapeutics, Inc. (373110) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE